Grade My Investments
HomeFree Stock Grades › AVNS

Avanos Medical, Inc. (AVNS) Stock Grade

AVNS · Healthcare

A+
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$521.1M
P/E Ratio
Revenue Growth (YoY)
+2.0%
Net Margin
-9.7%
Return on Equity
Dividend Yield
None

About Avanos Medical, Inc.'s fundamentals

Avanos Medical is a medical device company with a market capitalization of $521.1 million that generated modest revenue growth of 2.0% year-over-year. The company currently operates unprofitably with a net margin of -9.7% and reported a net loss in its latest annual statement. Despite the accounting losses, Avanos maintains positive free cash flow, suggesting the company is generating cash from operations even as it absorbs losses on its income statement. The company does not pay a dividend.

Track AVNS free — no credit card required. Live grade + monthly AI report →